Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Spruce Biosciences Inc (NASDAQ: SPRB) closed at $0.43 down -3.18% from its previous closing price of $0.44. In other words, the price has decreased by -$3.18 from its previous closing price. On the day, 0.72 million shares were traded. SPRB stock price reached its highest trading level at $0.4548 during the session, while it also had its lowest trading level at $0.42.
Ratios:
For a deeper understanding of Spruce Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.17 and its Current Ratio is at 5.17. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on March 14, 2024, Downgraded its rating to Sector Perform and sets its target price to $2 from $9 previously.
On March 14, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $9 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 21 ’24 when Novo Holdings A/S sold 465,021 shares for $0.75 per share. The transaction valued at 350,951 led to the insider holds 2,550,000 shares of the business.
Novo Holdings A/S sold 842,020 shares of SPRB for $647,008 on Mar 18 ’24. The 10% Owner now owns 3,968,000 shares after completing the transaction at $0.77 per share. On Mar 19 ’24, another insider, Novo Holdings A/S, who serves as the 10% Owner of the company, sold 593,000 shares for $0.76 each. As a result, the insider received 447,715 and left with 3,375,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRB now has a Market Capitalization of 17594908 and an Enterprise Value of -48396092. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.84 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at -5.056 whereas that against EBITDA is 1.02.
Stock Price History:
Over the past 52 weeks, SPRB has reached a high of $5.95, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -11.81%, while the 200-Day Moving Average is calculated to be -72.94%.
Shares Statistics:
For the past three months, SPRB has traded an average of 423.66K shares per day and 449490 over the past ten days. A total of 41.03M shares are outstanding, with a floating share count of 28.51M. Insiders hold about 30.96% of the company’s shares, while institutions hold 24.10% stake in the company. Shares short for SPRB as of 1724976000 were 252082 with a Short Ratio of 0.60, compared to 1722384000 on 135025. Therefore, it implies a Short% of Shares Outstanding of 252082 and a Short% of Float of 0.64.
